Moro-Valdezate D, Martin-Arevalo J, Cozar-Lozano C, Garcia-Botello S, Perez-Santiago L, Casado-Rodrigo D
Int J Colorectal Dis. 2025; 40(1):58.
PMID: 40045061
PMC: 11882633.
DOI: 10.1007/s00384-025-04848-3.
Ergani S, Aksan A, Kamaci C, Seyhanli Z, Ibanolu M, Akdas Reis Y
Malawi Med J. 2025; 36(3):208-212.
PMID: 40018403
PMC: 11862857.
DOI: 10.4314/mmj.v36i3.6.
Ma H, Ma L, Yang L, Cai M, Wang Y, Li Y
BMC Cancer. 2025; 25(1):207.
PMID: 39910481
PMC: 11800499.
DOI: 10.1186/s12885-025-13595-1.
Popa C, Schlanger D, Aiolfi A, ElShafei M, Triantafyllou T, Theodorou D
Langenbecks Arch Surg. 2025; 410(1):55.
PMID: 39875600
PMC: 11775071.
DOI: 10.1007/s00423-025-03617-8.
Bou Chebl R, Haidar S, Kattouf N, Assaf M, Alwan J, Khamis M
Open Access Emerg Med. 2025; 17:3-13.
PMID: 39867261
PMC: 11759577.
DOI: 10.2147/OAEM.S486966.
Evaluating the Role of CBC-Derived Indices in Children with Hashimoto's Thyroiditis.
Munteanu A, Juganaru I, Nicoara D, Mang N, Vasilescu R, Brad G
Diagnostics (Basel). 2025; 14(24.
PMID: 39767195
PMC: 11675751.
DOI: 10.3390/diagnostics14242834.
Landscape of Biomarkers and Pathologic Response in Rectal Cancer: Where We Stand?.
Ocanto A, Teja M, Amorelli F, Counago F, Gomez Palacios A, Alcaraz D
Cancers (Basel). 2024; 16(23).
PMID: 39682232
PMC: 11640609.
DOI: 10.3390/cancers16234047.
Effect of Low-dose Ketamine on Inflammatory Markers, Perioperative Analgesia, and Chronic Pain in Patients Undergoing Laparoscopic Inguinal Hernia Surgery: A Prospective, Randomized, Double-blind, Comparative Study.
Hallikeri S, Sinha R, Ray B, Pandey R, Darlong V, Punj J
Turk J Anaesthesiol Reanim. 2024; 52(6):231-239.
PMID: 39679693
PMC: 11650094.
DOI: 10.4274/TJAR.2024.241771.
TH1 Cell Frequency and Neutrophil-to-Lymphocyte Ratio in Hemodialysis: Potential Contributions to Patient Monitoring.
Rodrigues Barreto I, Monteiro A, Rocha E, Reis Santos C, Fonseca A
Biomedicines. 2024; 12(10).
PMID: 39457501
PMC: 11505415.
DOI: 10.3390/biomedicines12102188.
MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
Yan Q, Wu M, Zhang J, Yang J, Lv G, Qu B
Cancer Imaging. 2024; 24(1):144.
PMID: 39449107
PMC: 11515587.
DOI: 10.1186/s40644-024-00789-2.
Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy.
Hwang J, Kim S, Bang H, Kim H, Shim H, Bae W
Cancers (Basel). 2024; 16(19).
PMID: 39409972
PMC: 11475605.
DOI: 10.3390/cancers16193353.
The Importance of Predictive Biomarkers and Their Correlation with the Response to Immunotherapy in Solid Tumors-Impact on Clinical Practice.
Mihaila R, Gheorghe A, Zob D, Stanculeanu D
Biomedicines. 2024; 12(9).
PMID: 39335659
PMC: 11429372.
DOI: 10.3390/biomedicines12092146.
Neutrophil-to-lymphocyte ratio as an index of treatment response to trans-arterial chemoembolization in hepatocellular carcinoma.
Shayegan N, Ayoobi N, Mohammadi E, Saberi H, Salahshour F, Alborzi F
Gastroenterol Hepatol Bed Bench. 2024; 17(3):253-259.
PMID: 39308535
PMC: 11413382.
DOI: 10.22037/ghfbb.v17i3.2925.
Association between SII and markers of liver injury: A cross-sectional study from the NHANES (2017-2020).
Zhang X, Qin Y
PLoS One. 2024; 19(7):e0303398.
PMID: 39052624
PMC: 11271860.
DOI: 10.1371/journal.pone.0303398.
Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer.
Utsumi M, Inagaki M, Kitada K, Tokunaga N, Yunoki K, Okabayashi H
PLoS One. 2024; 19(6):e0305844.
PMID: 38913646
PMC: 11195994.
DOI: 10.1371/journal.pone.0305844.
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
Matsuda R, Maeoka R, Morimoto T, Nakazawa T, Morisaki Y, Yokoyama S
J Neurooncol. 2024; 168(3):487-494.
PMID: 38658464
DOI: 10.1007/s11060-024-04692-5.
Meta-analysis of the Relationship Between Neutrophil to Lymphocyte Ratio and Nasal Polyps.
Khanzadeh S, Ghaedi A, Meidani F, Rahmati R, Bazrgar A, Lucke-Wold B
Indian J Otolaryngol Head Neck Surg. 2024; 76(2):2191-2204.
PMID: 38566738
PMC: 10982268.
DOI: 10.1007/s12070-023-04306-y.
Exploratory Evaluation of Pre-Treatment Inflammation Profiles in Patients with Colorectal Cancer.
Feier C, Muntean C, Bolboaca S, Olariu S
Diseases. 2024; 12(3).
PMID: 38534985
PMC: 10969462.
DOI: 10.3390/diseases12030061.
The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma.
Seretis K, Sfaelos K, Boptsi E, Gaitanis G, Bassukas I
Cancers (Basel). 2024; 16(5).
PMID: 38473401
PMC: 10931327.
DOI: 10.3390/cancers16051044.
Hematological Indices for Identifying Adverse Outcomes in Children Admitted to Pediatric ICUs.
Mahalingam S, Bhaskar V, Batra P, Dewan P, Gogoi P
Cureus. 2024; 16(2):e53744.
PMID: 38465050
PMC: 10920964.
DOI: 10.7759/cureus.53744.